{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:05Z","timestamp":1707525125818},"reference-count":59,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,10]]},"DOI":"10.7759\/cureus.41650","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T16:57:54Z","timestamp":1689008274000},"source":"Crossref","is-referenced-by-count":0,"title":["Diffusion-Weighted Images and Contrast-Enhanced MRI in the Diagnosis of Different Stages of Multiple Sclerosis of the Central Nervous System"],"prefix":"10.7759","author":[{"given":"Mashael A","family":"Ismail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naglaa M","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis - a review","volume":"26","author":"Dobson R","year":"2019","unstructured":"Dobson R, Giovannoni G. Multiple sclerosis - a review. Eur J Neurol. 2019, 26:27-40. 10.1111\/ene.13819","journal-title":"Eur J Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis: a review","volume":"325","author":"McGinley MP","year":"2021","unstructured":"McGinley MP, Goldschmidt CH, Rae-Grant AD. Diagnosis and treatment of multiple sclerosis: a review. JAMA. 2021, 325:765-79. 10.1001\/jama.2020.26858","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000768","article-title":"Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity","volume":"83","author":"Browne P","year":"2014","unstructured":"Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV, Thompson AJ. Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity. Neurology. 2014, 83:1022-4. 10.1212\/WNL.0000000000000768","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition","volume":"26","author":"Walton C","year":"2020","unstructured":"Walton C, King R, Rechtman L, et al.. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 2020, 26:1816-21. 10.1177\/1352458520970841","journal-title":"Mult Scler"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-1629-3","article-title":"Rising prevalence of multiple sclerosis in Saudi Arabia, a descriptive study","volume":"20","author":"AlJumah M","year":"2020","unstructured":"AlJumah M, Bunyan R, Al Otaibi H, et al.. Rising prevalence of multiple sclerosis in Saudi Arabia, a descriptive study. BMC Neurol. 2020, 20:49. 10.1186\/s12883-020-1629-3","journal-title":"BMC Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518799580","article-title":"Symptomatology and symptomatic treatment in multiple sclerosis: results from a nationwide MS registry","volume":"25","author":"Rommer PS","year":"2019","unstructured":"Rommer PS, Eichst\u00e4dt K, Ellenberger D, et al.. Symptomatology and symptomatic treatment in multiple sclerosis: results from a nationwide MS registry. Mult Scler. 2019, 25:1641-52. 10.1177\/1352458518799580","journal-title":"Mult Scler"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2015.00021","article-title":"Fatigue in multiple sclerosis: a look at the role of poor sleep","volume":"6","author":"Strober LB","year":"2015","unstructured":"Strober LB. Fatigue in multiple sclerosis: a look at the role of poor sleep. Front Neurol. 2015, 6:21. 10.3389\/fneur.2015.00021","journal-title":"Front Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.09.002","article-title":"Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey","volume":"26","author":"Nazareth TA","year":"2018","unstructured":"Nazareth TA, Rava AR, Polyakov JL, Banfe EN, Waltrip Ii RW, Zerkowski KB, Herbert LB. Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey. Mult Scler Relat Disord. 2018, 26:219-34. 10.1016\/j.msard.2018.09.002","journal-title":"Mult Scler Relat Disord"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3109\/00207454.2012.762364","article-title":"Spasticity in multiple sclerosis: results of a patient survey","volume":"123","author":"Oreja-Guevara C","year":"2013","unstructured":"Oreja-Guevara C, Gonz\u00e1lez-Segura D, Vila C. Spasticity in multiple sclerosis: results of a patient survey. Int J Neurosci. 2013, 123:400-8. 10.3109\/00207454.2012.762364","journal-title":"Int J Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1212\/01.CON.0000433286.92596.d5","article-title":"Gait disorders in multiple sclerosis","volume":"19","author":"Bethoux F","year":"2013","unstructured":"Bethoux F. Gait disorders in multiple sclerosis. Continuum (Minneap Minn). 2013, 19:1007-22. 10.1212\/01.CON.0000433286.92596.d5","journal-title":"Continuum (Minneap Minn)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2013.04.004","article-title":"Vision and multiple sclerosis","volume":"3","author":"Hickman SJ","year":"2014","unstructured":"Hickman SJ, Raoof N, McLean RJ, Gottlob I. Vision and multiple sclerosis. Mult Scler Relat Disord. 2014, 3:3-16. 10.1016\/j.msard.2013.04.004","journal-title":"Mult Scler Relat Disord"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517750010","article-title":"Inner ear involvement in multiple sclerosis: an underestimated condition?","volume":"24","author":"Di Stadio A","year":"2018","unstructured":"Di Stadio A, Ralli M. Inner ear involvement in multiple sclerosis: an underestimated condition?. Mult Scler. 2018, 24:1264-5. 10.1177\/1352458517750010","journal-title":"Mult Scler"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-016-0741-z","article-title":"Bladder dysfunction in multiple sclerosis: a 6-year follow-up study","volume":"117","author":"Kisic Tepavcevic D","year":"2017","unstructured":"Kisic Tepavcevic D, Pekmezovic T, Dujmovic Basuroski I, Mesaros S, Drulovic J. Bladder dysfunction in multiple sclerosis: a 6-year follow-up study. Acta Neurol Belg. 2017, 117:83-90. 10.1007\/s13760-016-0741-z","journal-title":"Acta Neurol Belg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-801914-6.00024-6","article-title":"Treatment of acute relapses in multiple sclerosis","author":"Berkovich R","year":"2016","unstructured":"Berkovich R. Treatment of acute relapses in multiple sclerosis. Translational Neuroimmunology in Multiple Sclerosis. Academic Press, Cambridge, MA; 2016. 307-26. 10.1016\/B978-0-12-801914-6.00024-6"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.4410","article-title":"Multiple sclerosis: pathology, diagnosis and treatments","volume":"13","author":"Huang WJ","year":"2017","unstructured":"Huang WJ, Chen WW, Zhang X. Multiple sclerosis: pathology, diagnosis and treatments. Exp Ther Med. 2017, 13:3163-6. 10.3892\/etm.2017.4410","journal-title":"Exp Ther Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/sjhs.sjhs_163_21","article-title":"Multiple sclerosis in saudi arabia: a literature review","volume":"10","author":"Al-Saeed OM","year":"2021","unstructured":"Al-Saeed OM, Albogami MF, and Hatem M. Multiple sclerosis in saudi arabia: a literature review. Multiple sclerosis. 2021, 10:160-4. 10.4103\/sjhs.sjhs_163_21","journal-title":"Multiple sclerosis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000206","article-title":"Classification, diagnosis, and differential diagnosis of multiple sclerosis","volume":"28","author":"Katz Sand I","year":"2015","unstructured":"Katz Sand I. Classification, diagnosis, and differential diagnosis of multiple sclerosis. Curr Opin Neurol. 2015, 28:193-205. 10.1097\/WCO.0000000000000206","journal-title":"Curr Opin Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson A J","year":"2018","unstructured":"Thompson A J, Banwell B L, Barkhof F, et al.. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018, 17:162-73. 10.1016\/S1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.835162","article-title":"Sex-specific environmental impacts on initiation and progression of multiple sclerosis","volume":"13","author":"Leffler J","year":"2022","unstructured":"Leffler J, Trend S, Gorman S, Hart PH. Sex-specific environmental impacts on initiation and progression of multiple sclerosis. Front Neurol. 2022, 13:835162. 10.3389\/fneur.2022.835162","journal-title":"Front Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2020190204","article-title":"RadioGraphics update: white matter diseases with radiologic-pathologic correlation","volume":"40","author":"Sarbu N","year":"2020","unstructured":"Sarbu N, Shih RY, Oleaga L, Smirniotopoulos JG. RadioGraphics update: white matter diseases with radiologic-pathologic correlation. Radiographics. 2020, 40:E4-7. 10.1148\/rg.2020190204","journal-title":"Radiographics"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich DS","year":"2018","unstructured":"Reich DS, Lucchinetti CF, Calabresi PA. Multiple sclerosis. N Engl J Med. 2018, 378:169-80. 10.1056\/NEJMra1401483","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1159\/000360528","article-title":"Multiple sclerosis: current knowledge and future outlook","volume":"72","author":"Kamm CP","year":"2014","unstructured":"Kamm CP, Uitdehaag BM, Polman CH. Multiple sclerosis: current knowledge and future outlook. Eur Neurol. 2014, 72:132-41. 10.1159\/000360528","journal-title":"Eur Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70064-8","article-title":"The changing demographic pattern of multiple sclerosis epidemiology","volume":"9","author":"Koch-Henriksen N","year":"2010","unstructured":"Koch-Henriksen N, S\u00f8rensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010, 9:520-32. 10.1016\/S1474-4422(10)70064-8","journal-title":"Lancet Neurol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/4226141","article-title":"Prevalence of pediatric onset multiple sclerosis in Saudi Arabia","volume":"2021","author":"Bunyan R","year":"2021","unstructured":"Bunyan R, Al Towaijri G, Al Otaibi H, et al.. Prevalence of pediatric onset multiple sclerosis in Saudi Arabia. Mult Scler Int. 2021, 2021:4226141. 10.1155\/2021\/4226141","journal-title":"Mult Scler Int"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2015.106","article-title":"Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process","volume":"11","author":"Rovira \u00c0","year":"2015","unstructured":"Rovira \u00c0, Wattjes MP, Tintor\u00e9 M, et al.. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process. Nat Rev Neurol. 2015, 11:471-82. 10.1038\/nrneurol.2015.106","journal-title":"Nat Rev Neurol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman CH","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, et al.. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011, 69:292-302. 10.1002\/ana.22366","journal-title":"Ann Neurol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A4501","article-title":"Quantitative MRI for analysis of active multiple sclerosis lesions without gadolinium-based contrast agent","volume":"37","author":"Blystad I","year":"2016","unstructured":"Blystad I, H\u00e5kansson I, Tisell A, Ernerudh J, Smedby \u00d6, Lundberg P, Larsson EM. Quantitative MRI for analysis of active multiple sclerosis lesions without gadolinium-based contrast agent. AJNR Am J Neuroradiol. 2016, 37:94-100. 10.3174\/ajnr.A4501","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.49.2.364","article-title":"Multiple sclerosis lesion detection in the brain: a comparison of fast fluid-attenuated inversion recovery and conventional T2-weighted dual spin echo","volume":"49","author":"Gawne-Cain ML","year":"1997","unstructured":"Gawne-Cain ML, O'Riordan JI, Thompson AJ, Moseley IF, Miller DH. Multiple sclerosis lesion detection in the brain: a comparison of fast fluid-attenuated inversion recovery and conventional T2-weighted dual spin echo. Neurology. 1997, 49:364-70. 10.1212\/wnl.49.2.364","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1177\/1756285617708911","article-title":"MRI in the assessment and monitoring of multiple sclerosis: an update on best practice","volume":"10","author":"Kaunzner UW","year":"2017","unstructured":"Kaunzner UW, Gauthier SA. MRI in the assessment and monitoring of multiple sclerosis: an update on best practice. Ther Adv Neurol Disord. 2017, 10:247-61. 10.1177\/1756285617708911","journal-title":"Ther Adv Neurol Disord"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00393-2","article-title":"MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines","volume":"15","author":"Filippi M","year":"2016","unstructured":"Filippi M, Rocca MA, Ciccarelli O, et al.. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol. 2016, 15:292-303. 10.1016\/S1474-4422(15)00393-2","journal-title":"Lancet Neurol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.196.2.7617868","article-title":"Suspected multiple sclerosis: MR imaging with a thin-section fast FLAIR pulse sequence","volume":"196","author":"Hashemi RH","year":"1995","unstructured":"Hashemi RH, Bradley WG Jr, Chen DY, Jordan JE, Queralt JA, Cheng AE, Henrie JN. Suspected multiple sclerosis: MR imaging with a thin-section fast FLAIR pulse sequence. Radiology. 1995, 196:505-10. 10.1148\/radiology.196.2.7617868","journal-title":"Radiology"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13669","article-title":"'No evidence of disease activity' - is it an appropriate surrogate in multiple sclerosis?","volume":"25","author":"Hegen H","year":"2018","unstructured":"Hegen H, Bsteh G, Berger T. 'No evidence of disease activity' - is it an appropriate surrogate in multiple sclerosis?. Eur J Neurol. 2018, 25:1107-e101. 10.1111\/ene.13669","journal-title":"Eur J Neurol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/120.7.1149","article-title":"Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging","volume":"120","author":"Silver NC","year":"1997","unstructured":"Silver NC, Good CD, Barker GJ, et al.. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. Brain. 1997, 120:1149-61. 10.1093\/brain\/120.7.1149","journal-title":"Brain"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.5152\/eurasianjmed.2019.18473","article-title":"Is it possible to discriminate active MS lesions with diffusion weighted imaging?","volume":"51","author":"Unal S","year":"2019","unstructured":"Unal S, Peker E, Erdogan S, Erden MI. Is it possible to discriminate active MS lesions with diffusion weighted imaging?. Eurasian J Med. 2019, 51:219-23. 10.5152\/eurasianjmed.2019.18473","journal-title":"Eurasian J Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2016.09.006","article-title":"The evaluation of MRI diffusion values of active demyelinating lesions in multiple sclerosis","volume":"10","author":"Abdoli M","year":"2016","unstructured":"Abdoli M, Chakraborty S, MacLean HJ, Freedman MS. The evaluation of MRI diffusion values of active demyelinating lesions in multiple sclerosis. Mult Scler Relat Disord. 2016, 10:97-102. 10.1016\/j.msard.2016.09.006","journal-title":"Mult Scler Relat Disord"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.01082","article-title":"Characterization of contrast-enhancing and non-contrast-enhancing multiple sclerosis lesions using susceptibility-weighted imaging","volume":"10","author":"Eisele P","year":"2019","unstructured":"Eisele P, Fischer K, Szabo K, Platten M, Gass A. Characterization of contrast-enhancing and non-contrast-enhancing multiple sclerosis lesions using susceptibility-weighted imaging. Front Neurol. 2019, 10:1082. 10.3389\/fneur.2019.01082","journal-title":"Front Neurol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.01.027","article-title":"Temporal evolution of acute multiple sclerosis lesions on serial sodium ((23)Na) MRI","volume":"29","author":"Eisele P","year":"2019","unstructured":"Eisele P, Konstandin S, Szabo K, et al.. Temporal evolution of acute multiple sclerosis lesions on serial sodium ((23)Na) MRI. Mult Scler Relat Disord. 2019, 29:48-54. 10.1016\/j.msard.2019.01.027","journal-title":"Mult Scler Relat Disord"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-307650","article-title":"Imaging outcomes for trials of remyelination in multiple sclerosis","volume":"85","author":"Mallik S","year":"2014","unstructured":"Mallik S, Samson RS, Wheeler-Kingshott CA, Miller DH. Imaging outcomes for trials of remyelination in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2014, 85:1396-404. 10.1136\/jnnp-2014-307650","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A5773","article-title":"Gadolinium and multiple sclerosis: vessels, barriers of the brain, and glymphatics","volume":"39","author":"Saade C","year":"2018","unstructured":"Saade C, Bou-Fakhredin R, Yousem DM, Asmar K, Naffaa L, El-Merhi F. Gadolinium and multiple sclerosis: vessels, barriers of the brain, and glymphatics. AJNR Am J Neuroradiol. 2018, 39:2168-76. 10.3174\/ajnr.A5773","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.05.2212","article-title":"Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions","volume":"188","author":"Uysal E","year":"2007","unstructured":"Uysal E, Erturk SM, Yildirim H, Seleker F, Basak M. Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions. AJR Am J Roentgenol. 2007, 188:697-702. 10.2214\/AJR.05.2212","journal-title":"AJR Am J Roentgenol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00095-8","article-title":"MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis","volume":"20","author":"Wattjes P","year":"2021","unstructured":"Wattjes P, Ciccarelli O, Reich S, et al.. MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol. 2021, 20:653-70. 10.1016\/S1474-4422(21)00095-8","journal-title":"Lancet Neurol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520911174","article-title":"Gadolinium should always be used to assess disease activity in MS - Yes","volume":"26","author":"Granziera C","year":"2020","unstructured":"Granziera C, Reich DS. Gadolinium should always be used to assess disease activity in MS - Yes. Mult Scler. 2020, 26:765-6. 10.1177\/1352458520911174","journal-title":"Mult Scler"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.7224\/1537-2073-14.2.58","article-title":"The need for screening, assessment, and treatment for cognitive dysfunction in multiple sclerosis: results of a multidisciplinary CMSC Consensus Conference, September 24, 2010","volume":"14","author":"Foley FW","year":"2012","unstructured":"Foley FW, Benedict RH, Gromisch ES, Deluca J. The need for screening, assessment, and treatment for cognitive dysfunction in multiple sclerosis: results of a multidisciplinary CMSC Consensus Conference, September 24, 2010. Int J MS Care. 2012, 14:58-64. 10.7224\/1537-2073-14.2.58","journal-title":"Int J MS Care"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1097\/RCT.0000000000000767","article-title":"Standardizing magnetic resonance imaging protocols, requisitions, and reports in multiple sclerosis: an update for radiologist based on 2017 Magnetic Resonance Imaging in Multiple Sclerosis and 2018 Consortium of Multiple Sclerosis Centers Consensus Guidelines","volume":"43","author":"Arevalo O","year":"2019","unstructured":"Arevalo O, Riascos R, Rabiei P, Kamali A, Nelson F. Standardizing magnetic resonance imaging protocols, requisitions, and reports in multiple sclerosis: an update for radiologist based on 2017 Magnetic Resonance Imaging in Multiple Sclerosis and 2018 Consortium of Multiple Sclerosis Centers Consensus Guidelines. J Comput Assist Tomogr. 2019, 43:1-12. 10.1097\/RCT.0000000000000767","journal-title":"J Comput Assist Tomogr"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.nic.2016.12.002","article-title":"Brain and spinal cord MR imaging features in multiple sclerosis and variants","volume":"27","author":"Dekker I","year":"2017","unstructured":"Dekker I, Wattjes MP. Brain and spinal cord MR imaging features in multiple sclerosis and variants. Neuroimaging Clin N Am. 2017, 27:205-27. 10.1016\/j.nic.2016.12.002","journal-title":"Neuroimaging Clin N Am"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/S0074-7742(07)79017-7","article-title":"Gender issues in multiple sclerosis","volume":"79","author":"Schwendimann RN","year":"2007","unstructured":"Schwendimann RN, Alekseeva N. Gender issues in multiple sclerosis. Int Rev Neurobiol. 2007, 79:377-92. 10.1016\/S0074-7742(07)79017-7","journal-title":"Int Rev Neurobiol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/7854_2022_324","article-title":"Immune cell contributors to the female sex bias in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"62","author":"Alvarez-Sanchez N","year":"2023","unstructured":"Alvarez-Sanchez N, Dunn SE. Immune cell contributors to the female sex bias in multiple sclerosis and experimental autoimmune encephalomyelitis. Curr Top Behav Neurosci. 2023, 62:333-73. 10.1007\/7854_2022_324","journal-title":"Curr Top Behav Neurosci"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13004","article-title":"Impact of sex hormones on immune function and multiple sclerosis development","volume":"156","author":"Ysrraelit MC","year":"2019","unstructured":"Ysrraelit MC, Correale J. Impact of sex hormones on immune function and multiple sclerosis development. Immunology. 2019, 156:9-22. 10.1111\/imm.13004","journal-title":"Immunology"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000031126","article-title":"Correlation between ER\u03b1 gene polymorphism and multiple sclerosis and neuromyelitis optica","volume":"101","author":"Xing W","year":"2022","unstructured":"Xing W, Hong M, Wei Z, Zhang W. Correlation between ER\u03b1 gene polymorphism and multiple sclerosis and neuromyelitis optica. Medicine (Baltimore). 2022, 101:e31126. 10.1097\/MD.0000000000031126","journal-title":"Medicine (Baltimore)"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513519840","article-title":"Pregnancy, sex and hormonal factors in multiple sclerosis","volume":"20","author":"Miller DH","year":"2014","unstructured":"Miller DH, Fazekas F, Montalban X, Reingold SC, Trojano M. Pregnancy, sex and hormonal factors in multiple sclerosis. Mult Scler. 2014, 20:527-36. 10.1177\/1352458513519840","journal-title":"Mult Scler"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00616","article-title":"SeXX matters in multiple sclerosis","volume":"11","author":"Gilli F","year":"2020","unstructured":"Gilli F, DiSano KD, Pachner AR. SeXX matters in multiple sclerosis. Front Neurol. 2020, 11:616. 10.3389\/fneur.2020.00616","journal-title":"Front Neurol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122686","article-title":"Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS","volume":"10","author":"Ribbons KA","year":"2015","unstructured":"Ribbons KA, McElduff P, Boz C, et al.. Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS. PLoS One. 2015, 10:e0122686. 10.1371\/journal.pone.0122686","journal-title":"PLoS One"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120338","article-title":"Impact of post-contrast MRI in the definition of active multiple sclerosis","volume":"440","author":"Gentili L","year":"2022","unstructured":"Gentili L, Capuano R, Gaetani L, et al.. Impact of post-contrast MRI in the definition of active multiple sclerosis. J Neurol Sci. 2022, 440:120338. 10.1016\/j.jns.2022.120338","journal-title":"J Neurol Sci"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.22088\/cjim.11.4.432","article-title":"Delayed phases of contrast MRI, can it be valuable in multiple sclerosis active phase diagnosis?","volume":"11","author":"Pajouhan-Far H","year":"2020","unstructured":"Pajouhan-Far H, Qaemian N, Hajian-Tilaki K, Nabahati M, Saadat P, Mehraein R. Delayed phases of contrast MRI, can it be valuable in multiple sclerosis active phase diagnosis?. Caspian J Intern Med. 2020, 11:432-6. 10.22088\/cjim.11.4.432","journal-title":"Caspian J Intern Med"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrnm.2017.12.006","article-title":"Delayed post contrast magnetic resonance imaging (MRI) of the brain in multiple sclerosis (MS) patients: is it of value?","volume":"49","author":"Emara DM","year":"2018","unstructured":"Emara DM, El Abd AM, El Fatatry AM. Delayed post contrast magnetic resonance imaging (MRI) of the brain in multiple sclerosis (MS) patients: is it of value?. Egypt J Radiol Nuclear Med. 2018, 49:181-9. 10.1016\/j.ejrnm.2017.12.006","journal-title":"Egypt J Radiol Nuclear Med"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.5812\/iranjradiol.21740","article-title":"Diffusion weighted imaging in acute attacks of multiple sclerosis","volume":"13","author":"Davoudi Y","year":"2016","unstructured":"Davoudi Y, Foroughipour M, Torabi R, Layegh P, Matin N, Shoeibi A. Diffusion weighted imaging in acute attacks of multiple sclerosis. Iran J Radiol. 2016, 13:e21740. 10.5812\/iranjradiol.21740","journal-title":"Iran J Radiol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/S0720-048X(98)00131-4","article-title":"Diffusion-weighted MR imaging in multiple sclerosis: Comparison with contrast-enhanced study","volume":"31","author":"Tsuchiya K","year":"1999","unstructured":"Tsuchiya K, Hachiya J, Maehara T. Diffusion-weighted MR imaging in multiple sclerosis: Comparison with contrast-enhanced study. Eur J Radiol. 1999, 31:165-9. 10.1016\/S0720-048X(98)00131-4","journal-title":"Eur J Radiol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-14-100","article-title":"Comparison of diffusion-weighted imaging and contrast-enhanced T1-weighted imaging on a single baseline MRI for demonstrating dissemination in time in multiple sclerosis","volume":"14","author":"Lo CP","year":"2014","unstructured":"Lo CP, Kao HW, Chen SY, et al.. Comparison of diffusion-weighted imaging and contrast-enhanced T1-weighted imaging on a single baseline MRI for demonstrating dissemination in time in multiple sclerosis. BMC Neurol. 2014, 14:100. 10.1186\/1471-2377-14-100","journal-title":"BMC Neurol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrnm.2018.07.006","article-title":"Validity of apparent diffusion coefficient (ADC) value in diagnosis and follow-up of multiple sclerosis patients in different clinical subtypes","volume":"49","author":"Mohammed F","year":"2018","unstructured":"Mohammed F, Ismail H. Validity of apparent diffusion coefficient (ADC) value in diagnosis and follow-up of multiple sclerosis patients in different clinical subtypes. Egypt J Radiol Nuclear Med. 2018, 49:1103-9. 10.1016\/j.ejrnm.2018.07.006","journal-title":"Egypt J Radiol Nuclear Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/167329-diffusion-weighted-images-and-contrast-enhanced-mri-in-the-diagnosis-of-different-stages-of-multiple-sclerosis-of-the-central-nervous-system","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:03:29Z","timestamp":1707509009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/167329-diffusion-weighted-images-and-contrast-enhanced-mri-in-the-diagnosis-of-different-stages-of-multiple-sclerosis-of-the-central-nervous-system"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":59,"URL":"https:\/\/doi.org\/10.7759\/cureus.41650","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,10]]}}}